Kestra Medical Technologies (KMTS) Preferred Stock Liabilities (2024 - 2025)

Kestra Medical Technologies (KMTS) reported Preferred Stock Liabilities of $280.5 million for Q1 2025, up 58.38% quarter-over-quarter from $177.1 million in Q2 2024.

Kestra Medical Technologies (KMTS) Preferred Stock Liabilities (2024 - 2025) Analysis & Trends

Kestra Medical Technologies (KMTS) has 2 years of Preferred Stock Liabilities data on file, last reported at $280.5 million in Q1 2025.

  • Preferred Stock Liabilities for Q1 2025 came in at $280.5 million, changed N/A year-over-year; the trailing twelve-month figure through Jan 2025 was $280.5 million (changed N/A YoY), and the FY2024 annual result was $177.1 million, changed N/A from the prior year.
  • Preferred Stock Liabilities rose to $280.5 million in Q1 2025 per KMTS's latest filing, from $177.1 million in the prior quarter.
  • Over five years, Preferred Stock Liabilities peaked at $280.5 million in Q1 2025 and troughed at $177.1 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -
10 Kestra Medical Technologies 1.02 Bn 732.25 Mn 12.91 Mn -

Historic Data

Download Data
DateValue
Jan 31, 2025 280.51 Mn
Apr 30, 2024 177.11 Mn